| 标题 |
Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Immunology, Immunotherapy 作者:Mathilde Bureau; Thierry Chatellier; Tanguy Perennec; Thomas Goronflot; Charlotte Greilsamer; et al 出版日期:2021-11-28 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)